Eli Lilly and Company's Fiscal Year is From January To December.
The item "Ebit-Interest-Coverage" stands at 26.09 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Ebit Interest Coverage" stands at 26.09. This represents an increase of 33.61 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 66.97 percent compared to the value the year prior.
The 1 year change in percent is 66.97.
The 3 year change in percent is 24.77.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Ebit Interest Coverage | 486,508,953,600.00 |
![]() | AbbVie Inc - Ebit Interest Coverage | 399,570,305,024.00 |
![]() | Roche Holding AG - Ebit Interest Coverage | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Ebit Interest Coverage | 280,205,508,085.11 |
![]() | Novartis AG - Ebit Interest Coverage | 255,096,620,580.91 |